Codexis, Inc. (CDXS)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
Feb 20, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Codexis EPS Diluted (Quarterly) : -0.2173 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 1.462 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.62M |
| Revenue (Quarterly) | 8.601M |
| Total Expenses (Quarterly) | 28.22M |
| Enterprise Value | 115.11M |
| Gross Profit Margin (Quarterly) | 56.02% |
| Profit Margin (Quarterly) | -228.1% |
| Earnings Yield | -64.21% |
| Normalized Earnings Yield | -62.02 |